UM Sarcoidosis Program recently launched a new App for management of sarcoidosis. Learn more about it in the section of "For Physicians" on this page.
Our new Artificial Intelligence tool for patients with sarcoidosis. click here for access.
Currently, our Center is developing and validating molecular diagnostic tests to personalized Sarcoidosis treatment. The Program is also working in the discovery and implementation of companion components to improve treatment outcome. We are proud to announce that, in collaboration with Dr. Irman Forghani from UM Department of Medical Genetics, our patients would be tested for pharmacogenetics.
The 1st Patient Sarcoidosis Conference was held in UM. Dr. Forghani, Dr. Diana Laura, and Dr. Mirsaeidi discussed different clinical presentations of sarcoidosis and application of pharmacogenetics in sarcoidosis.
Afternoon, attendees discussed the critical lack of knowledge on sarcoidosis in community
and potential ways to improve it.
A new sarcoidosis patient support group has been formed and will be support south Florida sarcoidosis patients.
The AMSAR-Bio network is an open collaboration. Anyone with an interest in sarcoidosis can join and take part in Network activities. For more information about joining the network please visit our membership information. Please see our AMSAR-Bio website at
UM Sarcoidosis Program is recognized by the World Association for Sarcoidosis and Other Granulomatous Diseases (WASOG) as a WASOG Sarcoidosis Clinic. This designation provides formal recognition of our team’s commitment to deliver the needs of sarcoidosis patients and efforts to keep abreast of the ongoing advances and findings in the field.
The 1st UM Sarcoidosis Patient Conference was held in UM on April 07, 2018.
Lean more about our research projects in our Research section. We are happy to partner with other centers worldwide for the advancement of Sarcoidosis Research.